NEUBASE THERAPEUTICS INC (64132K201) Stock Institutional Owners
NEUBASE THERAPEUTICS INC (64132K201) is held by 1 institutional investors with a total value of $100,912. This comprehensive analysis highlights the top institutional holders led by Greenlight Capital, and others, who collectively account for nearly 100% of the total institutional ownership.Greenlight Capital remains the largest institutional holder with a position worth $100,912. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- NEUBASE THERAPEUTICS INC (64132K201) stock institutional trading activity
- NEUBASE THERAPEUTICS INC (64132K201) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Greenlight Capital | David Einhorn | 0.00% | 136,350 | $100,912 |
Frequently asked questions about 64132K201
Who owns the most 64132K201 stock?
The largest holders of 64132K201 are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NEUBASE THERAPEUTICS INC (64132K201).
Is 64132K201 widely held by superinvestors?
Many widely followed stocks like 64132K201 appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly 64132K201 is represented among the institutional managers we track.